10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

[X] QUARTERLY  REPORT PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934

For the quarterly period ended June 30, 2013.

[  ] TRANSITION REPORT  PURSUANT  TO  SECTION  13  OR  15(d)  OF  THE SECURITIES  EXCHANGE  ACT  OF  1934

For the transition period from to.

Commission File Number   1-12273

ROPER INDUSTRIES, INC.

(Exact name of registrant as specified in its charter)

Delaware (State or other jurisdiction of incorporation or organization)	51-0263969 (I.R.S. Employer Identification No.)
6901 Professional Pkwy. East, Suite 200Sarasota, Florida(Address of principal executive offices)	34240 (Zip Code)
(941) 556-2601 (Registrant's telephone number, including area code)

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   þ Yes ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).  þ Yes ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act. (Check one):

þ Large accelerated filer	¨ Accelerated filer
¨ Non-accelerated filer    (do not check if smaller reporting company)	¨ Smaller reporting company

Indicate by check mark if the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  ¨ Yes þ No

The number of shares outstanding of the Registrant's common stock as of August 1, 2013 was 99,183,286.

ROPER INDUSTRIES, INC.

REPORT ON FORM 10-Q FOR THE QUARTERLY PERIOD ENDED JUNE 30, 2013

TABLE OF CONTENTS

		Page
PART I.	FINANCIAL INFORMATION
Item 1.	Financial Statements (unaudited):
	Condensed Consolidated Statements of Earnings	3
	Condensed Consolidated Statements of Comprehensive Income	4
	Condensed Consolidated Balance Sheets	5
	Condensed Consolidated Statements of Cash Flows	6
	Condensed Consolidated Statement of Changes in Stockholders' Equity	7
	Notes to Condensed Consolidated Financial Statements	8
Item 2.	Management's Discussion and Analysis of Financial Condition and Results of Operations	15
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	22
Item 4.	Controls and Procedures	23
PART II.	OTHER INFORMATION
Item 1.	Legal Proceedings	23
Item 1A.	Risk Factors	23
Item 6.	Exhibits	24
	Signatures	25

PART I. FINANCIAL INFORMATION

ITEM 1.FINANCIAL STATEMENTS

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Earnings (unaudited)

(in thousands, except per share data)

	Three months ended June 30,					Six months ended June 30,
	2013		2012			2013		2012
Net sales	$	784,010	$	724,872		$	1,521,145	$	1,435,938
Cost of sales		338,503		327,264			654,062		647,137
Gross profit		445,507		397,608			867,083		788,801
Selling, general and administrative expenses		265,761		218,824			502,160		439,713
Income from operations		179,746		178,784			364,923		349,088
Interest expense, net		22,361		15,077			43,219		30,560
Other income/(expense), net		2,536		(574	)		44		(1,064	)
Earnings before income taxes		159,921		163,133			321,748		317,464
Income taxes		48,568		48,320			85,481		94,342
Net earnings	$	111,353	$	114,813		$	236,267	$	223,122
Net earnings per share:
Basic	$	1.12	$	1.18		$	2.39	$	2.29
Diluted		1.11		1.15			2.36		2.24
Weighted average common shares outstanding:
Basic		99,089		97,460			98,983		97,249
Diluted		100,162		99,619			100,071		99,500
Dividends declared per common share	$	0.1650	$	0.1375		$	0.3300	$	0.2750

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (unaudited)

(in thousands)

	Three months ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Net earnings	$	111,353		$	114,813		$	236,267		$	223,122
Other comprehensive income/(loss), net of tax:
Foreign currency translation adjustments		(3,632	)		(33,208	)		(42,121	)		(14,047	)
Total other comprehensive income/(loss), net of tax		(3,632	)		(33,208	)		(42,121	)		(14,047	)
Comprehensive income	$	107,721		$	81,605		$	194,146		$	209,075

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Balance Sheets (unaudited)

(in thousands)

	June 30, 2013			December 31, 2012
ASSETS:
Cash and cash equivalents	$	374,571		$	370,590
Accounts receivable, net		547,572			526,408
Inventories, net		197,458			190,867
Deferred taxes		58,582			41,992
Unbilled receivables		84,319			72,193
Other current assets		65,633			43,492
Total current assets		1,328,135			1,245,542
Property, plant and equipment, net		115,677			110,397
Goodwill		4,521,774			3,868,857
Other intangible assets, net		2,084,677			1,698,867
Deferred taxes		86,579			78,644
Other assets		76,900			68,797
Total assets	$	8,213,742		$	7,071,104
LIABILITIES AND STOCKHOLDERS' EQUITY:
Accounts payable	$	139,296		$	138,340
Accrued compensation		83,862			110,724
Deferred revenue		209,249			185,912
Other accrued liabilities		171,050			128,351
Deferred taxes		10,595			3,868
Current portion of long-term debt, net		512,799			519,015
Total current liabilities		1,126,851			1,086,210
Long-term debt, net of current portion		2,245,424			1,503,107
Deferred taxes		856,551			707,278
Other liabilities		95,368			86,783
Total liabilities		4,324,194			3,383,378
Commitments and contingencies (Note 10)
Common stock		1,012			1,006
Additional paid-in capital		1,198,269			1,158,001
Retained earnings		2,693,421			2,489,858
Accumulated other comprehensive earnings		16,416			58,537
Treasury stock		(19,570	)		(19,676	)
Total stockholders' equity		3,889,548			3,687,726
Total liabilities and stockholders' equity	$	8,213,742		$	7,071,104

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statements of Cash Flows (unaudited)

(in thousands)

	Six months ended June 30,
	2013			2012
Cash flows from operating activities:
Net earnings	$	236,267		$	223,122
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment		18,742			18,950
Amortization of intangible assets		71,794			52,289
Amortization of deferred financing costs		1,802			1,181
Non-cash stock compensation		26,284			19,704
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable		10,636			(2,321	)
Unbilled receivables		(12,483	)		(10,244	)
Inventories		(10,362	)		(5,452	)
Accounts payable and accrued liabilities		(9,091	)		(20,371	)
Income taxes payable		(17,925	)		(18,615	)
Other, net		(4,657	)		2,540
Cash provided by operating activities		311,007			260,783
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired		(1,007,513	)		(36,872	)
Capital expenditures		(21,889	)		(20,532	)
Proceeds from sale of assets		1,349			1,018
Other, net		(35	)		(474	)
Cash used in investing activities		(1,028,088	)		(56,860	)
Cash flows from financing activities:
Proceeds from senior notes		800,000			-
Payments under revolving line of credit, net		(58,000	)		-
Principal payments on convertible notes		(1,671	)		(13,215	)
Cash premiums paid on convertible note conversions		(4,040	)		(19,149	)
Debt issuance costs		(7,517	)		-
Cash dividends to stockholders		(16,338	)		(26,673	)
Proceeds from stock based compensation, net		10,998			28,314
Stock award tax excess windfall benefit		5,654			11,070
Treasury stock sales		1,250			1,123
Other		576			(1,107	)
Cash provided by/(used in) financing activities		730,912			(19,637	)
Effect of foreign currency exchange rate changes on cash		(9,850	)		(3,489	)
Net increase in cash and cash equivalents		3,981			180,797
Cash and cash equivalents, beginning of period		370,590			338,101
Cash and cash equivalents, end of period	$	374,571		$	518,898

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Condensed Consolidated Statement of Changes in Stockholders' Equity (unaudited)

(in thousands)

	Common stock		Additional paid-in capital			Retained earnings			Accumulated other comprehensive earnings			Treasury stock			Total
Balances at December 31, 2012	$	1,006	$	1,158,001		$	2,489,858		$	58,537		$	(19,676	)	$	3,687,726
Net earnings		-		-			236,267			-			-			236,267
Stock option exercises		3		14,408			-			-			-			14,411
Treasury stock sold		-		1,144			-			-			106			1,250
Currency translation adjustments, net of $2,707 tax		-		-			-			(42,121	)		-			(42,121	)
Stock based compensation		-		26,289			-			-			-			26,289
Restricted stock activity		3		(3,402	)		-			-			-			(3,399	)
Stock option tax benefit, net of shortfalls		-		5,557			-			-			-			5,557
Conversion of senior subordinated convertible notes, net of $312 tax		-		(3,728	)		-			-			-			(3,728	)
Dividends declared		-		-			(32,704	)		-			-			(32,704	)
Balances at June 30, 2013	$	1,012	$	1,198,269		$	2,693,421		$	16,416		$	(19,570	)	$	3,889,548

See accompanying notes to condensed consolidated financial statements.

Roper Industries, Inc. and Subsidiaries

Notes to Condensed Consolidated Financial Statements (unaudited)

June 30, 2013

1. Basis of Presentation

The accompanying condensed consolidated financial statements for the three and six month periods ended June 30, 2013 and 2012 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Industries, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2012 financial position data included herein was derived from the audited consolidated financial statements included in the 2012 Annual Report on Form 10-K ("Annual Report") filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three and six month periods ended June 30, 2013 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.

2. Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.  Any ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

In July 2012, the FASB issued an amendment to accounting rules related to the testing of indefinite-lived intangibles.  The new accounting rules permit an entity to first assess qualitative factors to determine if it is more likely than not that an indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test prescribed under current accounting rules.   Roper adopted this guidance on January 1, 2013.  The guidance did not have an impact on the Company's results of operations, financial position or cash flows.

3. Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Basic shares outstanding		99,089		97,460		98,983		97,249
Effect of potential common stock:
Common stock awards		882		1,129		884		1,172
Senior subordinated convertible notes		191		1,030		204		1,079
Diluted shares outstanding		100,162		99,619		100,071		99,500

For the three and six month periods ended June 30, 2013 there were 579,350 and 587,350 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive; this compares to 401,600 and 408,100 outstanding stock options, respectively, that would have been antidilutive for the three and six month periods ended June 30, 2012.

4. Business Acquisitions

On May 1, 2013, Roper acquired 100% of the shares of Managed Health Care Associates, Inc. ("MHA"), in a $1.0 billion all-cash transaction.  MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical platform.  MHA is reported in the Medical & Scientific Imaging segment.

During the six month period ended June 30, 2013, the Company expensed transaction costs of $2.3 million related to the acquisition as corporate general and administrative expenses, as incurred.

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.  The allocation of the purchase price is considered preliminary pending final intangible asset valuations and tax adjustments.  Pro forma data has not been provided as the acquisition of MHA was not material to the Company's operations.

Current assets	$	59,813
Identifiable intangibles		465,500
Goodwill		679,999
Other assets		5,798
Total assets acquired		1,211,110
Current liabilities		(24,717	)
Long-term deferred tax liability		(164,319	)
Other liabilities		(6,524	)
Net assets acquired	$	1,015,550

The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue share obligation owed to customers that generated the administrative fees.

During the quarter ended June 30, 2013, a net of $18.5 million of these fair value adjustments was amortized, and at June 30, 2013 the receivable balance was $10.6 million, and the corresponding liability balance was $2.7 million.  The Company expects the remaining net balance of $7.9 million to be amortized during the third quarter of 2013.

The majority of the goodwill is not expected to be deductible for tax purposes.  Of the $466 million of intangible assets acquired, $28 million was assigned to trade names that are not subject to amortization. The remaining $438 million of acquired intangible assets have a weighted-average useful life of approximately 20 years. The intangible assets that make up that amount include customer relationships of $433 million (20 year weighted-average useful life) and technology of $5 million (3 year weighted-average useful life).

5. Stock Based Compensation

The Roper Industries, Inc. Amended and Restated 2006 Incentive Plan is a stock based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. The common stock sold to the employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock based compensation expense (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Stock based compensation	$	13,307	$	9,749	$	26,284	$	19,704
Tax effect recognized in net income		4,658		3,412		9,199		6,896
Windfall tax benefit/(shortfall), net		1,245		3,551		5,557		10,966

Stock Options - In the six month period ended June 30, 2013, 520,850 options were granted with a weighted average fair value of $36.55 per option. During the same period in 2012, 412,100 options were granted with a weighted average fair value of $29.39 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during the current and prior year six month periods using the Black-Scholes option-pricing model:

	Six months ended June 30,
	2013	2012
Fair value per share ($)	36.55	29.39
Risk-free interest rate (%)	0.78	0.82
Expected option life (years)	5.19	5.22
Expected volatility (%)	36.22	36.55
Expected dividend yield (%)	0.57	0.59

Cash received from option exercises for the six months ended June 30, 2013 and 2012 was $14.4 million and $28.3 million, respectively.

Restricted Stock Awards - During the six months ended June 30, 2013, 346,390 restricted stock awards were granted with a weighted average fair value of $116.45 per restricted share. During the same period in 2012, 290,307 awards were granted with a weighted average fair value of $94.05 per restricted share. All grants were issued at grant date fair value.

During the six months ended June 30, 2013, 118,962 restricted awards vested with a weighted average grant date fair value of $62.39 per restricted share, at a weighted average vest date fair value of $120.52 per restricted share.

Employee Stock Purchase Plan - During the six month periods ended June 30, 2013 and 2012, participants of the employee stock purchase plan purchased 10,712 and 12,329 shares, respectively, of Roper's common stock for total consideration of $1.25 million and $1.12 million, respectively. All shares were purchased from Roper's treasury shares.

6. Inventories

	June 30, 2013			December 31, 2012
	(in thousands)
Raw materials and supplies	$	123,437		$	121,573
Work in process		33,648			29,725
Finished products		84,639			81,536
Inventory reserves		(44,266	)		(41,967	)
	$	197,458		$	190,867

7. Goodwill and Other Intangible Assets

The carrying value of goodwill by segment is as follows (in thousands):

	Industrial Technology			Energy Systems & Controls			Medical & Scientific Imaging			RF Technology			Total
Balances at December 31, 2012	$	421,755		$	404,057		$	1,772,402		$	1,270,643		$	3,868,857
Additions		-			-			679,999			-			679,999
Other		-			-			(3,793	)		445			(3,348	)
Currency translation adjustments		(4,019	)		(2,400	)		(11,647	)		(5,668	)		(23,734	)
Balances at June 30, 2013	$	417,736		$	401,657		$	2,436,961		$	1,265,420		$	4,521,774

Other intangible assets are comprised of (in thousands):

	Cost		Accumulated amortization			Net book value
Assets subject to amortization:
Customer related intangibles	$	1,509,339	$	(379,535	)	$	1,129,804
Unpatented technology		198,609		(97,487	)		101,122
Software		160,520		(44,256	)		116,264
Patents and other protective rights		40,399		(20,312	)		20,087
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		331,590		-			331,590
Balances at December 31, 2012	$	2,241,957	$	(543,090	)	$	1,698,867
Assets subject to amortization:
Customer related intangibles	$	1,934,311	$	(426,269	)	$	1,508,042
Unpatented technology		210,943		(109,356	)		101,587
Software		160,245		(51,248	)		108,997
Patents and other protective rights		30,150		(21,420	)		8,730
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		357,321		-			357,321
Balances at June 30, 2013	$	2,694,470	$	(609,793	)	$	2,084,677

Amortization expense of other intangible assets was $69,773 and $50,336 during the six months ended June 30, 2013 and 2012, respectively.

8. Debt

On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018.  The notes were issued at 99.791% of their principal amount.  The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility.

The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013.

Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.

The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness.  The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness.  The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.

The Company has $500 million of senior notes maturing on August 15, 2013. It is the intent of the Company to use borrowings from its $1.5 billion revolving credit facility to repay these notes.

Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the six month period ended June 30, 2013, 3,522 notes were converted for $5.6 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.3 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.

At June 30, 2013, the conversion price on the outstanding notes was $466.17.  If converted at June 30, 2013, the value would exceed the $10 million principal amount of the notes by approximately $23 million and could result in the issuance of 188,732 shares of Roper's common stock.

9. Fair Value of Financial Instruments

Roper's debt at June 30, 2013 included $2.7 billion of fixed-rate senior notes with the following fair values (in millions):

$500 million senior notes due 2013	$	503
$400 million senior notes due 2017		394
$800 million senior notes due 2018		786
$500 million senior notes due 2019		582
$500 million senior notes due 2022		477

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt included $10 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.

The Company manages interest rate risk by maintaining a combination of fixed- and variable-rate debt, which may include interest rate swaps to convert fixed-rate debt to variable-rate debt, or to convert variable-rate debt to fixed-rate debt.   At June 30, 2013, an aggregate notional amount of $500 million in interest rate swaps designated as fair value hedges effectively changed Roper's $500 million senior notes due 2013 with a fixed interest rate of 6.625% to a variable-rate obligation at a weighted average spread of 4.377% plus the 3 month London Interbank Offered Rate ("LIBOR").

The swaps are recorded at fair value in the balance sheet as assets or liabilities, and the changes in fair value of both the interest rate swap and the hedged senior notes due 2013 are recorded as interest expense. At June 30, 2013, the fair value of the swap was an asset balance of $1.2 million and was reported in other current assets. There was a corresponding increase of $0.2 million in the notes being hedged, which was reported as current portion of long-term debt.  The impact on earnings for the six months ended June 30, 2013 was immaterial. The Company has determined the swaps to be Level 2 in the FASB fair value hierarchy, and uses inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks in order to value the instruments.

10. Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. It is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized.

A summary of the warranty accrual activity for the six months ended June 30, 2013 is presented below (in thousands):

Balance at December 31, 2012	$	9,755
Additions charged to costs and expenses*		14,935
Deductions		(5,900	)
Other		(243	)
Balance at June 30, 2013	$	18,547

* During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.

11. Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three months ended June 30,						Six months ended June 30,
	2013		2012		Change		2013		2012		Change
Net sales:
Industrial Technology	$	197,543	$	203,944	(3.1	)%	$	379,782	$	399,080		(4.8	)%
Energy Systems & Controls		155,331		154,737	0.4			300,973		303,339		(0.8	)
Medical & Scientific Imaging		207,957		150,921	37.8			408,401		313,732		30.2
RF Technology		223,179		215,270	3.7			431,989		419,787		2.9
Total	$	784,010	$	724,872	8.2	%	$	1,521,145	$	1,435,938		5.9	%
Gross profit:
Industrial Technology	$	101,844	$	102,770	(0.9	)%	$	195,155	$	201,433		(3.1	)%
Energy Systems & Controls		87,421		86,135	1.5			168,327		166,543		1.1
Medical & Scientific Imaging		138,416		96,212	43.9			273,285		202,398		35.0
RF Technology		117,826		112,491	4.7			230,316		218,427		5.4
Total	$	445,507	$	397,608	12.0	%	$	867,083	$	788,801		9.9	%
Operating profit*:
Industrial Technology	$	50,580	$	62,076	(18.5	)%	$	103,525	$	119,583		(13.4	)%
Energy Systems & Controls		41,634		40,202	3.6			77,356		75,859		2.0
Medical & Scientific Imaging		47,537		35,679	33.2			107,465		79,041		36.0
RF Technology		60,729		58,161	4.4			117,359		108,514		8.2
Total	$	200,480	$	196,118	2.2	%	$	405,705	$	382,997		5.9	%
Long-lived assets:
Industrial Technology	$	46,565	$	43,096	8.0	%
Energy Systems & Controls		19,361		18,892	2.5
Medical & Scientific Imaging		42,926		44,314	(3.1	)
RF Technology		28,298		28,639	(1.2	)
Total	$	137,150	$	134,941	1.6	%

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,734 and $17,334 for the three months ended June 30, 2013 and 2012, respectively, and $40,782 and $33,909 for the six months ended June 30, 2013 and 2012, respectively.

ITEM 2.MANAGEMENT'S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

You should read the following discussion in conjunction with Management's Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report for the year ended December 31, 2012 as filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") and the notes to our Condensed Consolidated Financial Statements included elsewhere in this report.

Information About Forward-Looking Statements

This report includes "forward-looking statements" within the meaning of the federal securities laws. In addition, we, or our executive officers on our behalf, may from time to time make forward-looking statements in reports and other documents we file with the SEC or in connection with oral statements made to the press, potential investors or others. All statements that are not historical facts are "forward-looking statements."  Forward-looking statements may be indicated by words or phrases such as "anticipate," "estimate," "plans," "expects," "projects," "should," "will," "believes" or "intends" and similar words and phrases. These statements reflect management's current beliefs and are not guarantees of future performance. They involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied in any forward-looking statement.

Examples of forward-looking statements in this report include but are not limited to statements regarding operating results, the success of our internal operating plans, our expectations regarding our ability to generate operating cash flows and reduce debt and associated interest expense, profit and cash flow expectations, the prospects for newly acquired businesses to be integrated and contribute to future growth and our expectations regarding growth through acquisitions. Important assumptions relating to the forward-looking statements include, among others, assumptions regarding demand for our products, the cost, timing and success of product upgrades and new product introductions, raw materials costs, expected pricing levels, the timing and cost of expected capital expenditures, expected outcomes of pending litigation, competitive conditions, general economic conditions and expected synergies relating to acquisitions, joint ventures and alliances. These assumptions could prove inaccurate. Although we believe that the estimates and projections reflected in the forward-looking statements are reasonable, our expectations may prove to be incorrect. Important factors that could cause actual results to differ materially from estimates or projections contained in the forward-looking statements include, but are not limited to:

· general economic conditions;

· difficulty making acquisitions and successfully integrating acquired businesses;

· any unforeseen liabilities associated with future acquisitions;

· limitations on our business imposed by our indebtedness;

· unfavorable changes in foreign exchange rates;

· difficulties associated with exports;

· risks and costs associated with our international sales and operations;

· increased directors' and officers' liability and other insurance costs;

· risk of rising interest rates;

· product liability and insurance risks;

· increased warranty exposure;

· future competition;

· the cyclical nature of some of our markets;

· reduction of business with large customers;

· risks associated with government contracts;

· changes in the supply of, or price for, raw materials, parts and components;

· environmental compliance costs and liabilities;

· risks and costs associated with asbestos-related litigation;

· potential write-offs of our substantial goodwill and other intangible assets;

· our ability to successfully develop new products;

· failure to protect our intellectual property;

· the effect of, or change in, government regulations (including tax);

· economic disruption caused by terrorist attacks, health crises or other unforeseen events; and

· the factors discussed in other reports filed with the SEC.

We believe these forward-looking statements are reasonable; however, you should not place undue reliance on any forward-looking statements, which are based on current expectations. Further, forward-looking statements speak only as of the date they are made, and we undertake no obligation to publicly update any of these statements in light of new information or future events.

Overview

Roper Industries, Inc. ("Roper," "we" or "us") is a diversified growth company that designs, manufactures and distributes radio frequency ("RF") products, services and application software, industrial technology products, energy systems and controls and medical and scientific imaging products and software. We market these products and services to a broad range of markets, including RF applications, medical, water, energy, research, education, software-as-a-service ("SaaS")-based information networks, security and other niche markets.

We pursue consistent and sustainable growth in earnings by emphasizing continuous improvement in the operating performance of our existing businesses and by acquiring other carefully selected businesses that offer high value-added services, engineered products and solutions and are capable of achieving growth and maintaining high margins. Our acquisitions have represented both financial bolt-ons and new strategic platforms. We strive for high cash and earnings returns from our investments.

Critical Accounting Policies

There were no material changes during the three or six month periods ended June 30, 2013 to the items that we disclosed as our critical accounting policies and estimates in "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations" in our 2012 Annual Report on Form 10-K filed on February 25, 2013.

Recently Issued Accounting Standards

Information regarding new accounting pronouncements is included in Note 2 of the notes to Condensed Consolidated Financial Statements.

Results of Operations

General

The following tables set forth selected information for the periods indicated. Dollar amounts are in thousands and percentages are the particular line item shown as a percentage of corresponding net sales. Percentages may not foot due to rounding.

	Three months ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Net sales:
Industrial Technology	$	197,543		$	203,944		$	379,782		$	399,080
Energy Systems & Controls		155,331			154,737			300,973			303,339
Medical & Scientific Imaging		207,957			150,921			408,401			313,732
RF Technology		223,179			215,270			431,989			419,787
Total	$	784,010		$	724,872		$	1,521,145		$	1,435,938
Gross profit:
Industrial Technology		51.6	%		50.4	%		51.4	%		50.5	%
Energy Systems & Controls		56.3			55.7			55.9			54.9
Medical & Scientific Imaging		66.6			63.7			66.9			64.5
RF Technology		52.8			52.3			53.3			52.0
Total		56.8			54.9			57.0			54.9
Selling, general & administrative expenses:
Industrial Technology		26.0	%		20.0	%		24.1	%		20.5	%
Energy Systems & Controls		29.5			29.7			30.2			29.9
Medical & Scientific Imaging		43.7			40.1			40.6			39.3
RF Technology		25.6			25.2			26.1			26.2
Total		31.3			27.8			30.3			28.3
Segment operating profit:
Industrial Technology		25.6	%		30.4	%		27.3	%		30.0	%
Energy Systems & Controls		26.8			26.0			25.7			25.0
Medical & Scientific Imaging		22.9			23.6			26.3			25.2
RF Technology		27.2			27.0			27.2			25.8
Total		25.6			27.1			26.7			26.7
Corporate administrative expenses		(2.6	)		(2.4	)		(2.7	)		(2.4	)
		22.9			24.7			24.0			24.3
Interest expense		(2.9	)		(2.1	)		(2.8	)		(2.1	)
Other income/(expense)		0.3			(0.1	)		-			(0.1	)
Earnings before income taxes		20.4			22.5			21.2			22.1
Income taxes		(6.2	)		(6.7	)		(5.6	)		(6.6	)
Net earnings		14.2	%		15.8	%		15.5	%		15.5	%

Three months ended June 30, 2013 compared to three months ended June 30, 2012

Net sales for the quarter ended June 30, 2013were $784.0 million as compared to $724.9 million in the prior year quarter, an increase of 8.2%. The increase was the result of a 7.9% increase in sales from acquisitions and organic growth of 0.5%, partially offset by a small foreign exchange impact.

In our Industrial Technology segment, net sales were down 3% to $197.5 million in the second quarter of 2013 as compared to $203.9 million in the second quarter of 2012, due primarily to the loss of a customer at our water metering business and lower sales at our materials testing business.  Gross margins increased to 51.6% for the second quarter of 2013 as compared to 50.4% in the second quarter of 2012 due to product mix. Selling, general and administrative ("SG&A") expenses as a percentage of net sales increased to 26.0% in the current year quarter from 20.0% in the prior year quarter due primarily to a $9.1 million pretax charge for warranty expense at one of our subsidiaries, Hansen Technologies, to provide its customers with replacements for refrigeration valves that included a vendor-supplied component that did not meet Roper quality standards. The resulting operating profit margins were 25.6% in the second quarter of 2013 as compared to 30.4% in the second quarter of 2012.

Net sales in our Energy Systems & Controls segment increased to $155.3 million during the second quarter of 2013 compared to $154.7 million in the second quarter of 2012.  The increase in sales was due to increased demand for control systems for oil and gas applications offset in part by lower sales of pressure sensors for industrial applications and non-destructive testing systems for nuclear plants.  Gross margins increased to 56.3% in the second quarter of 2013 compared to 55.7% in the second quarter of 2012 due to product mix. SG&A expenses as a percentage of net sales were 29.5% in the second quarter of 2013, compared to 29.7% in the prior year quarter. As a result, operating margins were 26.8% in the second quarter of 2013 as compared to 26.0% in the second quarter of 2012.

In our Medical & Scientific Imaging segment, net sales increased by 38% to $208.0 million in the second quarter of 2013 as compared to $150.9 million in the second quarter of 2012, due to acquisitions.  We experienced continued growth in our medical businesses, which was offset by weakness in camera sales into research markets.  Gross margins increased to 66.6% in the second quarter of 2013 from 63.7% in the second quarter of 2012 due primarily to additional sales from medical products which have a higher gross margin. SG&A expenses as a percentage of net sales increased to 43.7% in the second quarter of 2013 as compared to 40.1% in the second quarter of 2012 due to SG&A expenses at MHA in which the corresponding revenues were not recognizable under GAAP (see Note 4 of the notes to Condensed Consolidated Financial Statements). As a result, operating margins were 22.9% in the second quarter of 2013 as compared to 23.6% in the second quarter of 2012.

In our RF Technology segment, net sales were $223.2 million in the second quarter of 2013 as compared to $215.3 million in the second quarter of 2012, an increase of 4%. The increase was due primarily to growth in our toll and traffic, university card systems and security solutions businesses. Gross margins increased to 52.8% in the second quarter of 2013, as compared to 52.3% in the prior year quarter due to product mix. SG&A expenses as a percentage of net sales in the second quarter of 2013 was 25.6% as compared to 25.2% in the second quarter of 2012 due to product mix. As a result, operating profit margins were 27.2% in the second quarter of 2013 as compared to 27.0% in the second quarter of 2012.

Corporate expenses were $20.7 million, or 2.6% of sales, in the second quarter of 2013 as compared to $17.3 million, or 2.4% of sales, in the second quarter of 2012. The increase was due primarily to higher stock-based compensation resulting from higher stock prices.

Interest expense was $22.4 million in the second quarter of 2013 as compared to $15.1 million in the second quarter of 2012. The increase was due to higher average outstanding debt balances related to 2012 and 2013 acquisitions, offset in part by lower average interest rates.

Other income was $2.5 million in the second quarter of 2013, due primarily to a one-time pretax gain related to a legal settlement offset in part by foreign exchange losses at our non-U.S. based companies. Other expense was $0.6 million in the second quarter of 2012, due primarily to foreign exchange losses at our non-U.S. based companies.

Our second quarter effective income tax rate was 30.4% as compared to the prior year rate of 29.6%. The increase is due to increased revenues and resulting pretax income in higher tax jurisdictions, primarily the United States.

At June 30, 2013, the functional currencies of our European subsidiaries were stronger and our Canadian subsidiaries were weaker against the U.S. dollar compared to currency exchange rates at March 31, 2013. The currency changes resulted in a pretax decrease of $5 million in the foreign exchange component of comprehensive earnings for the current year quarter, $3 million of which was related to goodwill.  Goodwill changes from currency exchange rate changes do not directly affect our reported earnings or cash flows.  During the quarter ended June 30, 2013 the functional currencies of most of our European and Canadian subsidiaries were stronger against the U.S. dollar as compared to the quarter ended June 30, 2012, with the exception of the British pound, which was weaker in the current year quarter.  The difference between the operating profits for these companies for the second quarter of 2013 compared to the prior year quarter, translated into U.S. dollars, was less than 1%.

Net orders were $816.5 million for the quarter, 7% higher than the second quarter 2012 net order intake of $763.5 million, due primarily to acquisitions, which contributed 9% to the current quarter orders, offset in part by decreased orders in our toll and traffic and water metering businesses.  Overall, our order backlog at June 30, 2013 was up 17% as compared to June 30, 2012, due primarily to acquisitions.

	Net orders booked for thethree months ended June 30,				Order backlog as of June 30,
	2013		2012		2013		2012
Industrial Technology	$	204,506	$	202,120	$	132,911	$	147,917
Energy Systems & Controls		159,955		157,775		125,471		128,018
Medical & Scientific Imaging		210,233		148,386		250,319		120,329
RF Technology		241,817		255,195		519,787		486,051
	$	816,511	$	763,476	$	1,028,488	$	882,315

Six months ended June 30, 2013 compared to six months ended June 30, 2012

Net sales for the six months ended June 30, 2013 were $1.5 billion as compared to $1.4 billion in the prior year six month period, representing an increase of 5.9%. The increase is comprised of a 7.7% increase from acquisitions, offset in part by a 1.5% decrease in organic sales and a small foreign exchange impact.

In our Industrial Technology segment, net sales decreased by 5% to $379.8 million in the first six months of 2013 as compared to $399.1 million in the first six months of 2012.  The decrease was due primarily to the loss of a customer at our water metering business and lower sales at our materials testing business.  Gross margins increased to 51.4% for the first six months of 2013 as compared to 50.5% in the first six months of 2012 due to product mix.  SG&A expenses as a percentage of net sales were 24.1%, as compared to 20.5% in the prior year six month period due primarily to a $9.1 million pretax charge for warranty expense at one of our subsidiaries, Hansen Technologies, to provide its customers with replacements for refrigeration valves that included a vendor-supplied component that did not meet Roper quality standards.  The resulting operating profit margins were 27.3% in the first six months of 2013 as compared to 30.0% in the first six months of 2012.

Net sales in our Energy Systems & Controls segment were $301.0 million during the first six months of 2013 as compared to $303.3 million in the first six months of 2012, due to lower sales of pressure sensors for industrial applications which was offset in part by increased demand for control systems for oil and gas applications.  Gross margins increased to 55.9% in the first six months of 2013, compared to 54.9% in the first six months of 2012 due to product mix.  SG&A expenses as a percentage of net sales were 30.2% as compared to 29.9% in the prior year six month period due to product mix. Operating margins were 25.7% in the first six months of 2013 as compared to 25.0% in first six months of 2012.

In our Medical & Scientific Imaging segment net sales increased 30% to $408.4 million in the first six months of 2013 as compared to $313.7 million in the first six months of 2012.  The change was comprised of a 35% increase from acquisitions, a decrease in organic sales of 4% and negative 1% from foreign exchange.  We experienced weakness in our camera businesses which was offset in part by continued growth in our medical businesses.  Gross margins increased to 66.9% in the first six months of 2013 from 64.5% in the first six months of 2012, due primarily to additional sales from medical products which have a higher gross margin. SG&A expenses as a percentage of net sales increased to 40.6% in the six month period ended June 30, 2013 as compared to 39.3% in the prior year period due to SG&A expenses at MHA in which the corresponding revenues were not recognizable under GAAP (see Note 4 of the notes to Condensed Consolidated Financial Statements).  Operating margins were 26.3% in the first six months of 2013 as compared to 25.2% in the first six months of 2012.

In our RF Technology segment, net sales were $432.0 million in the first six months of 2013 compared to $419.8 million in the first six months of 2012, an increase of 3%. The increase was due primarily to growth in our toll and traffic, university card systems and security solutions businesses.  Gross margins increased to 53.3% in the first six months of 2013 as compared to 52.0% in the prior year six month period due to a more favorable mix in tolling and traffic management products and services.  SG&A expenses as a percentage of sales was relatively unchanged at 26.1% in the first six months of 2013 compared to 26.2% in the prior year period.  Operating profit margins were 27.2% in the first six months of 2013 as compared to 25.8% in the first six months of 2012.

Corporate expenses increased by $6.9 million to $40.8 million or 2.7% of sales, in the first half of 2013 as compared to $33.9 million, or 2.4% of sales, in the first half of 2012. The increase was due primarily to higher equity compensation as a result of higher stock prices.

Interest expense of $43.2 million for the first half of 2013 was $12.6 million higher as compared to $30.6 million in the first half of 2012.  The increase was due to higher average outstanding debt balances related to 2012 and 2013 acquisitions, offset in part by lower average interest rates.

Other income was $.04 million in the first half of 2013 due primarily to a one-time pretax gain related to a legal settlement offset by foreign exchange losses at our non-U.S. based companies, as compared to other expense in the first half of 2012 of $1.1 million, due primarily to foreign exchange losses at our non-U.S. based companies.

Income taxes were 26.6% of pretax earnings in the first six months of 2013, as compared to 29.7% in the first six months of 2012. The reduction was due to $6 million in discrete tax benefits related to the enactment of the American Taxpayer Relief Act of 2012 ("ATRA"), as well as a $6 million benefit from the adjustment of tax balances which were immaterial to any covered period, offset by increased revenues and resulting pretax income in higher tax jurisdictions, primarily the United States.

At June 30, 2013, the functional currencies of our European and Canadian subsidiaries were weaker against the U.S. dollar compared to currency exchange rates at December 31, 2012. The currency changes resulted in a pretax decrease of $45 million in the foreign exchange component of comprehensive earnings for the six months ended June 30, 2013, $24 million of which was related to goodwill.  Goodwill changes from currency exchange rate changes do not directly affect our reported earnings or cash flows.  During the six months ended June 30, 2013 the functional currencies of most of our European and our Canadian subsidiaries were stronger against the U.S. dollar as compared to the six months ended June 30, 2012, with the exception of the British pound, which was weaker in the current year period.  The difference between the operating profits for these companies for the six months ended June 30, 2013 compared to the six months ended June 30, 2012, translated into U.S. dollars, was approximately 1%.

Financial Condition, Liquidity and Capital Resources

Selected cash flows for the three and six month periods ended June 30, 2013 and 2012 were as follows (in millions):

	Three months ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Cash provided by/(used in):
Operating activities	$	139.7		$	119.3		$	311.0		$	260.8
Investing activities		(1,014.9	)		(28.1	)		(1,028.1	)		(56.9	)
Financing activities		819.7			(17.4	)		730.9			(19.6	)

Operating activities - Net cash provided by operating activities in the second quarter of 2013 was $20.4 million, or 17% higher than the second quarter of 2012, due primarily to improved receivables collection and increased earnings net of intangible amortization related to acquisitions.   In the six month period ending June 30, 2013, operating cash flow increased by $50.2 million, or 19% over the prior year six month period, due primarily to improved receivables collection and earnings net of intangible amortization related to acquisitions.

Investing activities - Cash used in investing activities during the second quarters of 2013 and 2012 as well as in the six months ended June 30, 2013 and 2012 was primarily for business acquisitions and capital expenditures.

Financing activities – Cash provided by financing activities in the second quarter of 2013 was primarily for principal debt borrowings for acquisitions, offset in part by principal debt payments and dividends.  Cash used in financing activities in the second quarter of 2012 was primarily for principal debt payments, dividends and cash redemption premiums on convertible debt, offset partially by stock option proceeds.  Cash provided by financing activities in the six month period ended June 30, 2013 was primarily for principal debt borrowings and stock option proceeds, offset in part by principal debt payments and dividends.  Cash used in financing activities in the six month period ended June 30, 2012 was primarily for principal debt payments, dividends and cash redemption premiums on convertible debt.

Total debt at June 30, 2013 consisted of the following (amounts in thousands):

$500 million senior notes due 2013*	$	500,156
$400 million senior notes due 2017		400,000
$800 million senior notes due 2018		800,000
$500 million senior notes due 2019		500,000
$500 million senior notes due 2022		500,000
Senior Subordinated Convertible Notes		10,121
Revolving Facility		42,000
Other		5,946
Total debt		2,758,223
Less current portion		512,799
Long-term debt	$	2,245,424

* Shown including fair value swap adjustment of $156.

The interest rate on borrowings under our $1.5 billion credit facility is calculated based upon various recognized indices plus a margin as defined in the credit agreement. At June 30, 2013, there were $42 million of outstanding borrowings under the facility.  At June 30, 2013, we had $5.9 million of other debt in the form of capital leases, several smaller facilities that allow for borrowings or the issuance of letters of credit in various foreign locations to support our non-U.S. businesses and $40 million of outstanding letters of credit.

On June 7, 2013, we completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due 2018. See Note 8 of the Notes to Condensed Consolidated Financial Statements for additional information regarding the notes.

The Company has $500 million of senior notes maturing on August 15, 2013. It is the intent of the Company to use borrowings from its $1.5 billion revolving credit facility to repay these notes.

The cash and short-term investments at our foreign subsidiaries at June 30, 2013 totaled $306 million.  Repatriation of these funds under current regulatory and tax law for use in domestic operations would expose us to additional taxes.  We expect existing cash and cash equivalents, cash generated by our U.S. operations, our unsecured credit facility, as well as our expected ability to access the capital markets, will be sufficient to fund operating requirements in the U.S. for the foreseeable future.

We were in compliance with all debt covenants related to our credit facilities throughout the six months ended June 30, 2013.

Net working capital (total current assets, excluding cash, less total current liabilities, excluding debt) was $339.5 million at June 30, 2013 compared to $307.8 million at December 31, 2012, reflecting increased working capital due primarily to increases in receivables partially offset by an increase in deferred revenue.

Total debt was $2.76 billion at June 30, 2013 compared to $2.02 billion at December 31, 2012 due to borrowings to fund acquisitions offset in part by the use of operating cash flows to reduce outstanding debt.  Our leverage is shown in the following table (in thousands):

	June 30, 2013			December 31, 2012
Total debt	$	2,758,223		$	2,022,122
Cash		(374,571	)		(370,590	)
Net debt		2,383,652			1,651,532
Stockholders' equity		3,889,548			3,687,726
Total net capital	$	6,273,200		$	5,339,258
Net debt / Total net capital		38.0	%		30.9	%

At June 30, 2013, we did not have any relationships with unconsolidated entities or financial partnerships, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes.

Capital expenditures of $21.9 million and $20.5 million were incurred during the six months ended June 30, 2013 and 2012, respectively. We expect capital expenditures for the balance of the year to be comparable to prior years as a percentage of sales.

Outlook

Current geopolitical uncertainties could adversely affect our business prospects. A significant terrorist attack or other global conflict could cause changes in world economies that would adversely affect us. It is impossible to isolate each of these factor's effects on current economic conditions. It is also impossible to predict with any reasonable degree of certainty what or when any additional events may occur that also will similarly disrupt the economy.

We maintain an active acquisition program; however, future acquisitions will be dependent on numerous factors and it is not feasible to reasonably estimate if or when any such acquisitions will occur and what the impact will be on our business, financial condition and results of operations. Such acquisitions may be financed by the use of existing credit lines, future cash flows from operations, the proceeds from the issuance of new debt or equity securities or some combination of these methods.

We anticipate that our businesses will generate positive cash flows from operating activities, and that these cash flows will permit the reduction of outstanding debt. However, the rate at which we can reduce our debt during 2013 (and reduce the associated interest expense) will be affected by, among other things, the financing and operating requirements of any new acquisitions and the financial performance of our existing companies; and none of these factors can be predicted with certainty.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

See "Item 7A - Quantitative and Qualitative Disclosures about Market Risk," in our 2012 Annual Report on Form 10-K. There were no material changes during the three or six month periods ended June 30, 2013.

ITEM 4.  CONTROLS AND PROCEDURES

As required by SEC rules, we have evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of the end of the period covered by this quarterly report ("Evaluation Date"). This evaluation was carried out under the supervision and with the participation of our management, including our principal executive officer and principal financial officer. Based on this evaluation as of the Evaluation Date, these officers have concluded that the design and operation of our disclosure controls and procedures are effective.

Our disclosure controls and procedures are designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), is recorded, processed, summarized and reported, within the time periods specified in the SEC's rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act are accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.

There were no changes to our internal controls during the period covered by this quarterly report that materially affected, or are reasonably likely to materially affect, our internal controls over financial reporting.

Part II.OTHER INFORMATION

Item 1.Legal Proceedings

Information pertaining to legal proceedings can be found in Note 10 of the Notes to Condensed Consolidated Financial Statements included elsewhere in this report, and is incorporated by reference herein.

Item 1A.Risk Factors

For information regarding factors that could affect our results of operations, financial condition and liquidity, see the risk factors discussion in Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2012 as filed on February 25, 2013 with the SEC. See also, "Information about Forward-Looking Statements" included in Part I, Item 2 of this Quarterly Report on Form 10-Q.

Item 6.Exhibits

4.1	Form of 2.05% Senior Notes due 2018, incorporated herein by reference to exhibit 4.1 to the Roper Industries, Inc. Current Report on Form 8-K filed June 6, 2013.
31.1	Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
31.2	Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
32.1	Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
101.INS	XBRL Instance Document, furnished herewith.
101.SCH	XBRL Taxonomy Extension Schema Document, furnished herewith.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.

Signatures

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Roper Industries, Inc.

/s/ Brian D. Jellison	Chairman of the Board, President,	August 7, 2013
Brian D. Jellison	and Chief Executive Officer
	(Principal Executive Officer)

/s/ John Humphrey	Chief Financial Officer and	August 7, 2013
John Humphrey	Executive Vice President
	(Principal Financial Officer)

/s/ Paul J. Soni	Vice President and Controller	August 7, 2013
Paul J. Soni	(Principal Accounting Officer)

EXHIBIT INDEX

TO REPORT ON FORM 10-Q

NumberExhibit

4.1	Form of 2.05% Senior Notes due 2018, incorporated herein by reference to Exhibit 4.1 to the Roper Industries, Inc. Current Report on Form 8-K filed June 6, 2013.
31.1	Rule 13a-14(a)/15d-14(a), Certification of the Chief Executive Officer, filed herewith.
31.2	Rule 13a-14(a)/15d-14(a), Certification of the Chief Financial Officer, filed herewith.
32.1	Section 1350 Certification of the Chief Executive and Chief Financial Officers, filed herewith.
101.INS	XBRL Instance Document, furnished herewith.
101.SCH	XBRL Taxonomy Extension Schema Document, furnished herewith.
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document, furnished herewith.
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document, furnished herewith.
101.LAB	XBRL Taxonomy Extension Label Linkbase Document, furnished herewith.
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document, furnished herewith.

EX-31.1

Exhibit 31.1

I, Brian D. Jellison, certify that:

1. I have reviewed this Quarterly Report on Form 10-Q of Roper Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter  (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 7, 2013         /s/ Brian D. Jellison

Brian D. Jellison

Chairman, President and

Chief Executive Officer

EX-31.2

Exhibit 31.2

I, John Humphrey, certify that:

1I have reviewed this Quarterly Report on Form 10-Q of Roper Industries, Inc.;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter  (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: August 7, 2013           /s/ John Humphrey

John Humphrey

Executive Vice President and

Chief Financial Officer

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Roper Industries, Inc. (the "Company") on Form 10-Q for the period ending June 30, 2013, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), Brian D. Jellison, Chief Executive Officer of the Company, and John Humphrey, Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of his knowledge that:

1. The Report fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934; and

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 7, 2013	/s/ Brian D. Jellison
	Brian D. Jellison
	Chairman, President and Chief Executive Officer
	(Principal Executive Officer)
	/s/ John Humphrey
	John Humphrey
	Executive Vice President and Chief Financial Officer
	(Principal Financial Officer)

This certificate is being made for the exclusive purpose of compliance of the Company with the requirements of Section 906 of the Sarbanes-Oxley Act of 2002, and may not be disclosed, distributed or used by any person or for any reason other than specifically required by law.

XML

Business Segments

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Business Segments

11. Business Segments

Sales and operating profit by industry segment are set forth in the following table (dollars in thousands):

	Three months endedJune 30,						Six months endedJune 30,
	2013		2012		Change		2013		2012		Change
Net sales:
Industrial Technology	$	197,543	$	203,944	(3.1	)%	$	379,782	$	399,080		(4.8	)%
Energy Systems & Controls		155,331		154,737	0.4			300,973		303,339		(0.8	)
Medical & Scientific Imaging		207,957		150,921	37.8			408,401		313,732		30.2
RF Technology		223,179		215,270	3.7			431,989		419,787		2.9
Total	$	784,010	$	724,872	8.2	%	$	1,521,145	$	1,435,938		5.9	%
Gross profit:
Industrial Technology	$	101,844	$	102,770	(0.9	)%	$	195,155	$	201,433		(3.1	)%
Energy Systems & Controls		87,421		86,135	1.5			168,327		166,543		1.1
Medical & Scientific Imaging		138,416		96,212	43.9			273,285		202,398		35.0
RF Technology		117,826		112,491	4.7			230,316		218,427		5.4
Total	$	445,507	$	397,608	12.0	%	$	867,083	$	788,801		9.9	%
Operating profit*:
Industrial Technology	$	50,580	$	62,076	(18.5	)%	$	103,525	$	119,583		(13.4	)%
Energy Systems & Controls		41,634		40,202	3.6			77,356		75,859		2.0
Medical & Scientific Imaging		47,537		35,679	33.2			107,465		79,041		36.0
RF Technology		60,729		58,161	4.4			117,359		108,514		8.2
Total	$	200,480	$	196,118	2.2	%	$	405,705	$	382,997		5.9	%
Long-lived assets:
Industrial Technology	$	46,565	$	43,096	8.0	%
Energy Systems & Controls		19,361		18,892	2.5
Medical & Scientific Imaging		42,926		44,314	(3.1	)
RF Technology		28,298		28,639	(1.2	)
Total	$	137,150	$	134,941	1.6	%

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,734 and $17,334 for the three months ended June 30, 2013 and 2012, respectively, and $40,782 and $33,909 for the six months ended June 30, 2013 and 2012, respectively.

XML

Condensed Consolidated Balance Sheets (unaudited) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Assets
Cash and cash equivalents	$ 374,571	$ 370,590
Accounts receivable, net	547,572	526,408
Inventories, net	197,458	190,867
Deferred taxes	58,582	41,992
Unbilled receivables	84,319	72,193
Other current assets	65,633	43,492
Total current assets	1,328,135	1,245,542
Property, plant and equipment, net	115,677	110,397
Goodwill	4,521,774	3,868,857
Other intangible assets, net	2,084,677	1,698,867
Deferred taxes	86,579	78,644
Other assets	76,900	68,797
Total assets	8,213,742	7,071,104
Liabilities and Stockholders' Equity
Accounts payable	139,296	138,340
Accrued Compensation	83,862	110,724
Deferred Revenue, Current	209,249	185,912
Accrued liabilities	171,050	128,351
Deferred taxes	10,595	3,868
Current portion of long-term debt, net	512,799	519,015
Total current liabilities	1,126,851	1,086,210
Long-term debt, net of current portion	2,245,424	1,503,107
Deferred taxes	856,551	707,278
Other liabilities	95,368	86,783
Total liabilities	4,324,194	3,383,378
Common stock	1,012	1,006
Additional paid-in capital	1,198,269	1,158,001
Retained earnings	2,693,421	2,489,858
Accumulated other comprehensive earnings	16,416	58,537
Treasury stock	(19,570)	(19,676)
Total stockholders' equity	3,889,548	3,687,726
Total liabilities and stockholders' equity	$ 8,213,742	$ 7,071,104

XML

Business Acquisitions

6 Months Ended

Jun. 30, 2013

Business Acquisitions [Abstract]

Business Acquisitions [Text Block]

4. Business Acquisitions

On May 1, 2013, Roper acquired 100% of the shares of Managed Health Care Associates, Inc. ("MHA"), in a $1.0 billion all-cash transaction.  MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting. The acquisition of MHA complements and expands the Company's medical platform.  MHA is reported in the Medical & Scientific Imaging segment.

During the six month period ended June 30, 2013, the Company expensed transaction costs of $2.3 million related to the acquisition as corporate general and administrative expenses, as incurred.

The following table (in thousands) summarizes the fair values of the assets acquired and liabilities assumed at the date of acquisition.  The allocation of the purchase price is considered preliminary pending final intangible asset valuations and tax adjustments.  Pro forma data has not been provided as the acquisition of MHA was not material to the Company's operations.

Current assets	$	59,813
Identifiable intangibles		465,500
Goodwill		679,999
Other assets		5,798
Total assets acquired		1,211,110
Current liabilities		(24,717	)
Long-term deferred tax liability		(164,319	)
Other liabilities		(6,524	)
Net assets acquired	$	1,015,550

The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue share obligation owed to customers that generated the administrative fees.

During the quarter ended June 30, 2013, a net of $18.5 million of these fair value adjustments was amortized, and at June 30, 2013 the receivable balance was $10.6 million, and the corresponding liability balance was $2.7 million.  The Company expects the remaining net balance of $7.9 million to be amortized during the third quarter of 2013.

The majority of the goodwill is not expected to be deductible for tax purposes.  Of the $466 million of intangible assets acquired, $28 million was assigned to trade names that are not subject to amortization. The remaining $438 million of acquired intangible assets have a weighted-average useful life of approximately 20 years. The intangible assets that make up that amount include customer relationships of $433 million (20 year weighted-average useful life) and technology of $5 million (3 year weighted-average useful life).

XML

Fair Value of Financial Instruments (Tables)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Fair Value, Liabilities Measured on Recurring and Nonrecurring Basis [Table Text Block]

Roper's debt at June 30, 2013 included $2.7 billion of fixed-rate senior notes with the following fair values (in millions):

$500 million senior notes due 2013	$	503
$400 million senior notes due 2017		394
$800 million senior notes due 2018		786
$500 million senior notes due 2019		582
$500 million senior notes due 2022		477

XML

Earnings Per Share (Policies)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Earnings Per Share Policy

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

XML

Business Acquisitions (Details) (USD $)			6 Months Ended		6 Months Ended
	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 Mha Acquisition [Member]	May 01, 2013 Mha Acquisition [Member]	Jun. 30, 2013 Mha Acquisition [Member] Customer Relationships [Member]	Jun. 30, 2013 Mha Acquisition [Member] Unpatented Technology [Member]
Business Acquisition [Line Items]
Business Acquisition, Effective Date of Acquisition			May 01, 2013
Payments to Acquire Businesses, Gross			$ 1,000,000,000
Business Acquisition, Percentage of Voting Interests Acquired			100.00%
Name of Acquired Entity			Managed Health Care Associates, Inc. ("MHA")
Description of Acquired Entity			MHA is a leading provider of services and technologies to support the diverse and complex needs of alternate site health care providers who deliver services outside of an acute care hospital setting.
Reason for Business Combination			The acquisition of MHA complements and expands the Company's medical platform.
Cost of Acquired Entity Transaction Costs			2,300,000
Business Combination, Admin Fee Receivables [Abstract]
Business Combination, Acquired Receivables, Description			The fair value of current assets acquired also includes an adjustment of $35.0 million for administrative fees related to customer purchases that occurred prior to the acquisition date but not reported to MHA until after the acquisition date. In the ordinary course, these administrative fees are recorded as revenue when reported; however, GAAP accounting for business acquisitions requires the Company to estimate the amount of purchases occurring prior to the acquisition date and record the fair value of the administrative fees to be received from those purchases as an accounts receivable. The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue share obligation owed to customers that generated the administrative fees. During the quarter ended June 30, 2013, a net of $18.5 million of these fair value adjustments was amortized, and at June 30, 2013 the receivable balance was $10.6 million, and the corresponding liability balance was $2.7 million. The Company expects the remaining net balance of $7.9 million to be amortized during the third quarter of 2013.
Business Combination, Liability Related to Acquired Receivables, Description			The Company also recorded a fair value liability of $8.6 million included in current liabilities related to corresponding revenue share obligation owed to customers that generated the administrative fees.
Business Combination, Acquired Receivables, Fair Value			10,600,000	35,000,000
Business Combination, Liability Related to Acquired Receivables, Fair Value			2,700,000	8,600,000
Business Combination, Acquired Receivables, Fair Value Net of Liability			7,900,000
Indefinite-lived Intangible Assets Acquired			28,000,000
Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Less Noncontrolling Interest [Abstract]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Other			59,813,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Intangible Assets, Other than Goodwill, Total			465,500,000
Goodwill	4,521,774,000	3,868,857,000	679,999,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Other Noncurrent Assets			5,798,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Assets, Total			1,211,110,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other			24,717,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Noncurrent			164,319,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Noncurrent Liabilities, Other			6,524,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net, Total			1,015,550,000
Acquired Finite-Lived Intangible Assets [Line Items]
Finite-lived Intangible Assets Acquired					$ 433,000,000	$ 5,000,000
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life					20 years	3 years

XML

Earnings Per Share (Details)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Schedule Of Weighted Average Number Of Shares Outstanding Basic To Diluted
Basic shares outstanding	99,089,000	97,460,000	98,983,000	97,249,000
Effect of potential common stock
Common stock awards	882,000	1,129,000	884,000	1,172,000
Senior subordinated convertible notes	191,000	1,030,000	204,000	1,079,000
Diluted shares outstanding	100,162,000	99,619,000	100,071,000	99,500,000
Antidilutive stock options	579,350	401,600	587,350	408,100

XML

Contingencies (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Notes to Financial Statements [Abstract]
Standard Product Warranty Description	* During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.
Warranty Accrual Activity Table
Balance	$ 9,755
Additions charged to costs and expenses	14,935
Deductions	(5,900)
Other	(243)
Balance	$ 18,547

XML

Debt (Details) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Debt Instrument [Line Items]
Maturity Date	Jan. 15, 2034
Interest Rate (in hundredths)	3.75%
Senior Notes 2013 [Member]
Debt Instrument [Line Items]
Debt Instrument, Description	The Company has $500 million of senior notes maturing on August 15, 2013. It is the intent of the Company to use borrowings from its $1.5 billion revolving credit facility to repay these notes.
Senior Notes due 2018 [Member]
Debt Instrument [Line Items]
Debt Instrument, Description	On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018. The notes were issued at 99.791% of their principal amount. The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility. The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013. Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness. The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness. The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.
Issuance Date	Jun. 06, 2013
Principal amount (in millions)	$ 800
Maturity Date	Oct. 01, 2018
Periodic interest payments	semi-annually in arrears on April 1 and October 1 of each year
Periodic interest payments, start	October 1, 2013
Interest Rate (in hundredths)	2.05%

XML

Business Segments (Tables)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Sales and operating profit by business segment Table

	Three months endedJune 30,						Six months endedJune 30,
	2013		2012		Change		2013		2012		Change
Net sales:
Industrial Technology	$	197,543	$	203,944	(3.1	)%	$	379,782	$	399,080		(4.8	)%
Energy Systems & Controls		155,331		154,737	0.4			300,973		303,339		(0.8	)
Medical & Scientific Imaging		207,957		150,921	37.8			408,401		313,732		30.2
RF Technology		223,179		215,270	3.7			431,989		419,787		2.9
Total	$	784,010	$	724,872	8.2	%	$	1,521,145	$	1,435,938		5.9	%
Gross profit:
Industrial Technology	$	101,844	$	102,770	(0.9	)%	$	195,155	$	201,433		(3.1	)%
Energy Systems & Controls		87,421		86,135	1.5			168,327		166,543		1.1
Medical & Scientific Imaging		138,416		96,212	43.9			273,285		202,398		35.0
RF Technology		117,826		112,491	4.7			230,316		218,427		5.4
Total	$	445,507	$	397,608	12.0	%	$	867,083	$	788,801		9.9	%
Operating profit*:
Industrial Technology	$	50,580	$	62,076	(18.5	)%	$	103,525	$	119,583		(13.4	)%
Energy Systems & Controls		41,634		40,202	3.6			77,356		75,859		2.0
Medical & Scientific Imaging		47,537		35,679	33.2			107,465		79,041		36.0
RF Technology		60,729		58,161	4.4			117,359		108,514		8.2
Total	$	200,480	$	196,118	2.2	%	$	405,705	$	382,997		5.9	%
Long-lived assets:
Industrial Technology	$	46,565	$	43,096	8.0	%
Energy Systems & Controls		19,361		18,892	2.5
Medical & Scientific Imaging		42,926		44,314	(3.1	)
RF Technology		28,298		28,639	(1.2	)
Total	$	137,150	$	134,941	1.6	%

*Segment operating profit is before unallocated corporate general and administrative expenses. These expenses were $20,734 and $17,334 for the three months ended June 30, 2013 and 2012, respectively, and $40,782 and $33,909 for the six months ended June 30, 2013 and 2012, respectively.

XML

Condensed Consolidated Statements of Changes in Stockholders' Equity (unaudited) (USD $) In Thousands	Common stock	Additional paid-in capital	Retained earnings	Accumulated other comprehensive earnings	Treasury stock	Total
Beginning Balance at Dec. 31, 2012	$ 1,006	$ 1,158,001	$ 2,489,858	$ 58,537	$ (19,676)	$ 3,687,726
Net earnings	0	0	236,267	0	0	236,267
Stock option exercises	3	14,408	0	0	0	14,411
Treasury stock sold	0	1,144	0	0	106	1,250
Currency translation adjustments, net of tax	0	0	0	(42,121)	0	(42,121)
Stock based compensation	0	26,289	0	0	0	26,289
Restricted stock activity	3	(3,402)	0	0	0	(3,399)
Stock option tax benefit, net of shortfalls	0	5,557	0	0	0	5,557
Conversion of senior subordinated convertible notes	0	(3,728)	0	0	0	(3,728)
Dividends declared	0	0	(32,704)	0	0	(32,704)
Ending Balance at Jun. 30, 2013	$ 1,012	$ 1,198,269	$ 2,693,421	$ 16,416	$ (19,570)	$ 3,889,548

XML

Recent Accounting Pronouncements

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Recent Accounting Pronouncements

2. Recent Accounting Pronouncements

The Financial Accounting Standards Board ("FASB") establishes changes to accounting principles under GAAP in the form of accounting standards updates ("ASUs") to the FASB's Accounting Standards Codification.  The Company considers the applicability and impact of all ASUs.  Any ASUs not listed below were assessed and determined to be either not applicable or are expected to have an immaterial impact on the Company's results of operations, financial position or cash flows.

In July 2012, the FASB issued an amendment to accounting rules related to the testing of indefinite-lived intangibles.  The new accounting rules permit an entity to first assess qualitative factors to determine if it is more likely than not that an indefinite-lived asset is impaired as a basis for determining whether it is necessary to perform the quantitative impairment test prescribed under current accounting rules.   Roper adopted this guidance on January 1, 2013.  The guidance did not have an impact on the Company's results of operations, financial position or cash flows.

XML

Stock Based Compensation

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Stock-Based Compensation

5. Stock Based Compensation

The Roper Industries, Inc. Amended and Restated 2006 Incentive Plan is a stock based compensation plan used to grant incentive stock options, nonqualified stock options, restricted stock, stock appreciation rights or equivalent instruments to Roper's employees, officers and directors.

Roper's stock purchase plan allows employees in the U.S. and Canada to designate up to 10% of eligible earnings to purchase Roper's common stock at a 5% discount to the average closing price of the stock at the beginning and end of a quarterly offering period. The common stock sold to the employees may be either treasury stock, stock purchased on the open market, or newly issued shares.

The following table provides information regarding the Company's stock based compensation expense (in thousands):

	Three months endedJune 30,				Six months endedJune 30,
	2013		2012		2013		2012
Stock based compensation	$	13,307	$	9,749	$	26,284	$	19,704
Tax effect recognized in net income		4,658		3,412		9,199		6,896
Windfall tax benefit/(shortfall), net		1,245		3,551		5,557		10,966

Stock Options - In the six month period ended June 30, 2013, 520,850 options were granted with a weighted average fair value of $36.55 per option. During the same period in 2012, 412,100 options were granted with a weighted average fair value of $29.39 per option. All options were issued at grant date fair value, which is defined by the Plan as the closing price of Roper's common stock on the date of grant.

Roper records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. Historical data is used to estimate the expected price volatility, the expected dividend yield, the expected option life and the expected forfeiture rate. The risk-free rate is based on the U.S. Treasury yield curve in effect at the time of grant for the estimated life of the option. The following weighted average assumptions were used to estimate the fair value of options granted during the current and prior year six month periods using the Black-Scholes option-pricing model:

	Six months ended June 30,
	2013	2012
Fair value per share ($)	36.55	29.39
Risk-free interest rate (%)	0.78	0.82
Expected option life (years)	5.19	5.22
Expected volatility (%)	36.22	36.55
Expected dividend yield (%)	0.57	0.59

Cash received from option exercises for the six months ended June 30, 2013 and 2012 was $14.4 million and $28.3 million, respectively.

Restricted Stock Awards - During the six months ended June 30, 2013, 346,390 restricted stock awards were granted with a weighted average fair value of $116.45 per restricted share. During the same period in 2012, 290,307 awards were granted with a weighted average fair value of $94.05 per restricted share. All grants were issued at grant date fair value.

During the six months ended June 30, 2013, 118,962 restricted awards vested with a weighted average grant date fair value of $62.39 per restricted share, at a weighted average vest date fair value of $120.52 per restricted share.

Employee Stock Purchase Plan - During the six month periods ended June 30, 2013 and 2012, participants of the employee stock purchase plan purchased 10,712 and 12,329 shares, respectively, of Roper's common stock for total consideration of $1.25 million and $1.12 million, respectively. All shares were purchased from Roper's treasury shares.

XML

Earnings Per Share

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Earnings Per Share

3. Earnings Per Share

Basic earnings per share were calculated using net earnings and the weighted average number of shares of common stock outstanding during the respective period. Diluted earnings per share were calculated using net earnings and the weighted average number of shares of common stock and potential common stock outstanding during the respective period. Potentially dilutive common stock consisted of stock options and the premium over the conversion price on Roper's senior subordinated convertible notes based upon the trading price of Roper's common stock. The effects of potential common stock were determined using the treasury stock method.  Weighted average shares outstanding are as shown below (in thousands):

	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Basic shares outstanding		99,089		97,460		98,983		97,249
Effect of potential common stock:
Common stock awards		882		1,129		884		1,172
Senior subordinated convertible notes		191		1,030		204		1,079
Diluted shares outstanding		100,162		99,619		100,071		99,500

For the three and six month periods ended June 30, 2013 there were 579,350 and 587,350 outstanding stock options, respectively, that were not included in the determination of diluted earnings per share because doing so would have been antidilutive; this compares to 401,600 and 408,100 outstanding stock options, respectively, that would have been antidilutive for the three and six month periods ended June 30, 2012.

XML

Stock Based Compensation (Details) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Notes to Financial Statements [Abstract]
Percentage of eligible earnings to purchase common stock through the employee stock purchase plan	10.00%		10.00%
Discount on the average closing price for the employee stock purchase plan			5.00%
Stock Based Compensation Expense Table
Stock based compensation	$ 13,307,000	$ 9,749,000	$ 26,284,000	$ 19,704,000
Tax effect recognized in net income	4,658,000	3,412,000	9,199,000	6,896,000
Windfall tax benefit/(shortfall), net	1,245,000	3,551,000	5,557,000	10,966,000
Employee stock options granted during the period			520,850	412,100
Weighted average assumptions used to value option grants Table
Fair value per share ($)			$ 36.55	$ 29.39
Risk-free interest rate (%)			0.78%	0.82%
Expected option life (years)			5 years 2 months 12 days	5 years 2 months 19 days
Expected volatility (%)			36.22%	36.55%
Expected dividend yield (%)			0.57%	0.59%
Cash received from exercise of options			14,400,000	28,300,000
Restricted stock awards granted during period			346,390	290,307
Weighted average fair value per share of restricted stock awards granted during the period			$ 116.45	$ 94.05
Restricted stock awards vested during period			118,962
Weighted average grant date fair value per share			$ 62.39
Weighted average vest date fair value per share			$ 120.52
Shares of stock purchased during the period by participants in the employee stock purchase plan			10,712	12,329
Amount paid for stock purchased during the period by participants in the employee stock purchase plan			$ 1,250,000	$ 1,120,000

XML

Debt, Extinguishment (Details) (USD $) In Millions, except Per Share data, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Extinguishment of Debt [Line Items]
Stated Interest Rate Percentage - Debt Instruments	3.75%
Maturity Date - Debt Instrument	Jan. 15, 2034
First Conversion Date	Jan. 15, 2009
Number of Notes Converted	3,522
Cash Payments for Debt Conversions (in millions)	$ 5.6
Deferred Tax Liability (in millions)	0.3
Per Note Conversion Price	$ 466
Excess above Principal Note Amount (in millions)	$ 23
3.75% Senior Subordinated Convertible Notes, Due 2034
Extinguishment of Debt [Line Items]
If converted, issuance of common stock shares	188,732

XML

Condensed Consolidated Statements of Comprehensive Income (unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Condensed Consolidated Statements of Comprehensive Income (unaudited) [Abstract]
Net earnings	$ 111,353	$ 114,813	$ 236,267	$ 223,122
Comprehensive income, net of tax
Foreign currency translation adjustments	(3,632)	(33,208)	(42,121)	(14,047)
Total other comprehensive income, net of tax	(3,632)	(33,208)	(42,121)	(14,047)
Comprehensive income	$ 107,721	$ 81,605	$ 194,146	$ 209,075

XML

Debt

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Debt

8. Debt

On June 6, 2013, the Company completed a public offering of $800 million aggregate principal amount of 2.05% senior unsecured notes due October 1, 2018.  The notes were issued at 99.791% of their principal amount.  The net proceeds were used to pay a portion of the outstanding revolver balance under Roper's revolving credit facility.

The notes bear interest at a fixed rate of 2.05% per year, payable semi-annually in arrears on April 1 and October 1 of each year, beginning October 1, 2013.

Roper may redeem some or all of these notes at any time or from time to time, at 100% of their principal amount, plus a make-whole premium based on a spread to U.S. Treasury securities.

The notes are unsecured senior obligations of the Company and rank equally in right of payment with all of its existing and future unsecured and unsubordinated indebtedness.  The notes are effectively subordinated to any existing and future secured indebtedness to the extent of the value of the collateral securing such indebtedness.  The notes are not guaranteed by any of Roper's subsidiaries and are effectively subordinated to all existing and future indebtedness and other liabilities of its subsidiaries.

The Company has $500 million of senior notes maturing on August 15, 2013. It is the intent of the Company to use borrowings from its $1.5 billion revolving credit facility to repay these notes.

Roper's 3.75% senior subordinated convertible notes due 2034 became convertible on January 15, 2009.  During the six month period ended June 30, 2013, 3,522 notes were converted for $5.6 million in cash.  No gain or loss was recorded upon these conversions.  In addition, a related $0.3 million deferred tax liability associated with excess deductions recorded for tax purposes was relieved to additional paid-in capital upon the conversions.

At June 30, 2013, the conversion price on the outstanding notes was $466.17.  If converted at June 30, 2013, the value would exceed the $10 million principal amount of the notes by approximately $23 million and could result in the issuance of 188,732 shares of Roper's common stock.

XML

Condensed Consolidated Statements of Cash Flows (unaudited) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Cash flows from operating activities:
Net earnings	$ 236,267	$ 223,122
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property, plant and equipment	18,742	18,950
Amortization of intangible assets	71,794	52,289
Amortization of deferred financing costs	1,802	1,181
Non-cash stock compensation	26,284	19,704
Changes in operating assets and liabilities, net of acquired businesses:
Accounts receivable	10,636	(2,321)
Unbilled receivables	(12,483)	(10,244)
Inventories	(10,362)	(5,452)
Accounts payable and accrued liabilities	(9,091)	(20,371)
Income taxes	(17,925)	(18,615)
Other, net	(4,657)	2,540
Cash provided by operating activities	311,007	260,783
Cash flows from investing activities:
Acquisitions of businesses, net of cash acquired	(1,007,513)	(36,872)
Capital expenditures	(21,889)	(20,532)
Proceeds from sale of assets	1,349	1,018
Other, net	(35)	(474)
Cash used in investing activities	(1,028,088)	(56,860)
Cash flows from financing activities:
Proceeds from (Repayments of) Notes Payable	800,000	0
Borrowings/(payments) under revolving line of credit, net	(58,000)	0
Principal payments on convertible notes	(1,671)	(13,215)
Cash dividends to stockholders	(16,338)	(26,673)
Stock award tax excess windfall benefit	5,654	11,070
Payments of Debt Issuance Costs	(7,517)	0
Treasury stock sales	1,250	1,123
Proceeds from stock based compensation, net	10,998	28,314
Cash Premium on Convertible Debt	(4,040)	(19,149)
Other	576	(1,107)
Cash provided by/(used in) financing activities	730,912	(19,637)
Effect of foreign currency exchange rate changes on cash	(9,850)	(3,489)
Net increase/(decrease) in cash and cash equivalents	3,981	180,797
Cash and cash equivalents, end of period	370,590	338,101
Cash and cash equivalents, end of period	$ 374,571	$ 518,898

XML

Condensed Consolidated Statements of Earnings (unaudited) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Condensed Consolidated Statements of Earnings
Net sales	$ 784,010	$ 724,872	$ 1,521,145	$ 1,435,938
Cost of sales	338,503	327,264	654,062	647,137
Gross profit	445,507	397,608	867,083	788,801
Selling, general and administrative expenses	265,761	218,824	502,160	439,713
Income from operations	179,746	178,784	364,923	349,088
Interest expense	22,361	15,077	43,219	30,560
Other income/(expense)	2,536	(574)	44	(1,064)
Earnings before income taxes	159,921	163,133	321,748	317,464
Income taxes	48,568	48,320	85,481	94,342
Net earnings	$ 111,353	$ 114,813	$ 236,267	$ 223,122
Earnings per share:
Basic	$ 1.12	$ 1.18	$ 2.39	$ 2.29
Diluted	$ 1.11	$ 1.15	$ 2.36	$ 2.24
Weighted average common shares outstanding:
Basic	99,089	97,460	98,983	97,249
Diluted	100,162	99,619	100,071	99,500
Dividends declared per common share	$ 0.1650	$ 0.1375	$ 0.3300	$ 0.2750

XML

Inventories (Details) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Inventories
Raw materials and supplies	$ 123,437	$ 121,573
Work in process	33,648	29,725
Finished products	84,639	81,536
Inventory reserves	(44,266)	(41,967)
Total Inventory	$ 197,458	$ 190,867

XML

Goodwill and Other Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Goodwill

The carrying value of goodwill by segment is as follows (in thousands):

	Industrial Technology			Energy Systems & Controls			Medical & Scientific Imaging			RF Technology			Total
Balances at December 31, 2012	$	421,755		$	404,057		$	1,772,402		$	1,270,643		$	3,868,857
Additions		-			-			679,999			-			679,999
Other		-			-			(3,793	)		445			(3,348	)
Currency translation adjustments		(4,019	)		(2,400	)		(11,647	)		(5,668	)		(23,734	)
Balances at June 30, 2013	$	417,736		$	401,657		$	2,436,961		$	1,265,420		$	4,521,774

Other Intangible Assets

Other intangible assets are comprised of (in thousands):

	Cost		Accumulatedamortization			Net bookvalue
Assets subject to amortization:
Customer related intangibles	$	1,509,339	$	(379,535	)	$	1,129,804
Unpatented technology		198,609		(97,487	)		101,122
Software		160,520		(44,256	)		116,264
Patents and other protective rights		40,399		(20,312	)		20,087
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		331,590		-			331,590
Balances at December 31, 2012	$	2,241,957	$	(543,090	)	$	1,698,867
Assets subject to amortization:
Customer related intangibles	$	1,934,311	$	(426,269	)	$	1,508,042
Unpatented technology		210,943		(109,356	)		101,587
Software		160,245		(51,248	)		108,997
Patents and other protective rights		30,150		(21,420	)		8,730
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		357,321		-			357,321
Balances at June 30, 2013	$	2,694,470	$	(609,793	)	$	2,084,677

Amortization expense of other intangible assets was $69,773 and $50,336 during the six months ended June 30, 2013 and 2012, respectively.

XML

Business Segments (Details) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Segment Reporting Information [Line Items]
Net sales	$ 784,010	$ 724,872	$ 1,521,145	$ 1,435,938
Percent change in Net Sales	8.2		5.9
Gross Profit	445,507	397,608	867,083	788,801
Percent change in Gross Profit	12		9.9
Operating profit	200,480	196,118	405,705	382,997
Percent change in Operating Profit	2.2		5.9
Long-Lived assets	137,150	134,941	137,150	134,941
Percent change in Long-lived assets	1.6
Unallocated corporate general and administrative expenses	20,734	17,334	40,782	33,909
Industrial Technology
Segment Reporting Information [Line Items]
Net sales	197,543	203,944	379,782	399,080
Percent change in Net Sales	(3.1)		(4.8)
Gross Profit	101,844	102,770	195,155	201,433
Percent change in Gross Profit	(0.9)		(3.1)
Operating profit	50,580	62,076	103,525	119,583
Percent change in Operating Profit	(18.5)		(13.4)
Long-Lived assets	46,565	43,096	46,565	43,096
Percent change in Long-lived assets	8.0
Energy Systems And Controls
Segment Reporting Information [Line Items]
Net sales	155,331	154,737	300,973	303,339
Percent change in Net Sales	0.4		(0.8)
Gross Profit	87,421	86,135	168,327	166,543
Percent change in Gross Profit	1.5		1.1
Operating profit	41,634	40,202	77,356	75,859
Percent change in Operating Profit	3.6		2.0
Long-Lived assets	19,361	18,892	19,361	18,892
Percent change in Long-lived assets	2.5
Medical And Scientific Imaging
Segment Reporting Information [Line Items]
Net sales	207,957	150,921	408,401	313,732
Percent change in Net Sales	37.8		30.2
Gross Profit	138,416	96,212	273,285	202,398
Percent change in Gross Profit	43.9		35.0
Operating profit	47,537	35,679	107,465	79,041
Percent change in Operating Profit	33.2		36.0
Long-Lived assets	42,926	44,314	42,926	44,314
Percent change in Long-lived assets	(3.1)
RF Technology
Segment Reporting Information [Line Items]
Net sales	223,179	215,270	431,989	419,787
Percent change in Net Sales	3.7		2.9
Gross Profit	117,826	112,491	230,316	218,427
Percent change in Gross Profit	4.7		5.4
Operating profit	60,729	58,161	117,359	108,514
Percent change in Operating Profit	4.4		8.2
Long-Lived assets	$ 28,298	$ 28,639	$ 28,298	$ 28,639
Percent change in Long-lived assets	(1.2)

XML

Goodwill and Other Intangible Assets

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Goodwill and Intangible Assets Disclosure [Text Block]

7. Goodwill and Other Intangible Assets

The carrying value of goodwill by segment is as follows (in thousands):

	Industrial Technology			Energy Systems & Controls			Medical & Scientific Imaging			RF Technology			Total
Balances at December 31, 2012	$	421,755		$	404,057		$	1,772,402		$	1,270,643		$	3,868,857
Additions		-			-			679,999			-			679,999
Other		-			-			(3,793	)		445			(3,348	)
Currency translation adjustments		(4,019	)		(2,400	)		(11,647	)		(5,668	)		(23,734	)
Balances at June 30, 2013	$	417,736		$	401,657		$	2,436,961		$	1,265,420		$	4,521,774

Other intangible assets are comprised of (in thousands):

	Cost		Accumulatedamortization			Net bookvalue
Assets subject to amortization:
Customer related intangibles	$	1,509,339	$	(379,535	)	$	1,129,804
Unpatented technology		198,609		(97,487	)		101,122
Software		160,520		(44,256	)		116,264
Patents and other protective rights		40,399		(20,312	)		20,087
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		331,590		-			331,590
Balances at December 31, 2012	$	2,241,957	$	(543,090	)	$	1,698,867
Assets subject to amortization:
Customer related intangibles	$	1,934,311	$	(426,269	)	$	1,508,042
Unpatented technology		210,943		(109,356	)		101,587
Software		160,245		(51,248	)		108,997
Patents and other protective rights		30,150		(21,420	)		8,730
Trade secrets		1,500		(1,500	)		-
Assets not subject to amortization:
Trade names		357,321		-			357,321
Balances at June 30, 2013	$	2,694,470	$	(609,793	)	$	2,084,677

Amortization expense of other intangible assets was $69,773 and $50,336 during the six months ended June 30, 2013 and 2012, respectively.

XML

Goodwill and Other Intangible Assets (Details) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Goodwill [Line Items]
Balances	$ 3,868,857
Goodwill acquired	679,999
Goodwill, Other Changes	(3,348)
Currency translation adjustments	(23,734)
Balances	4,521,774
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	2,694,470		2,241,957
Accumulated amortization	(609,793)		(543,090)
Net book value	2,084,677		1,698,867
Amortization expense of other intangible assets	69,773	50,336
Assets subject to amortization | Customer related intangibles
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	1,934,311		1,509,339
Accumulated amortization	(426,269)		(379,535)
Net book value	1,508,042		1,129,804
Assets subject to amortization | Unpatented technology
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	210,943		198,609
Accumulated amortization	(109,356)		(97,487)
Net book value	101,587		101,122
Assets subject to amortization | Software
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	160,245		160,520
Accumulated amortization	(51,248)		(44,256)
Net book value	108,997		116,264
Assets subject to amortization | Patents and other protective rights
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	30,150		40,399
Accumulated amortization	(21,420)		(20,312)
Net book value	8,730		20,087
Assets subject to amortization | Trade secrets
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	1,500		1,500
Accumulated amortization	(1,500)		(1,500)
Net book value	0		0
Assets not subject to amortization | Trade names
Schedule Of Other Intangible Assets By Major Class [Line Items]
Cost	357,321		331,590
Accumulated amortization	0		0
Net book value	357,321		331,590
Industrial Technology
Goodwill [Line Items]
Balances	421,755
Goodwill acquired	0
Goodwill, Other Changes	0
Currency translation adjustments	(4,019)
Balances	417,736
Energy Systems And Controls
Goodwill [Line Items]
Balances	404,057
Goodwill acquired	0
Goodwill, Other Changes	0
Currency translation adjustments	(2,400)
Balances	401,657
Medical And Scientific Imaging
Goodwill [Line Items]
Balances	1,772,402
Goodwill acquired	679,999
Goodwill, Other Changes	(3,793)
Currency translation adjustments	(11,647)
Balances	2,436,961
RF Technology
Goodwill [Line Items]
Balances	1,270,643
Goodwill acquired	0
Goodwill, Other Changes	445
Currency translation adjustments	(5,668)
Balances	$ 1,265,420

XML

Contingencies

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Contingencies

10. Contingencies

Roper, in the ordinary course of business, is the subject of, or a party to, various pending or threatened legal actions, including product liability and employment practices. It is vigorously contesting all lawsuits that, in general, are based upon claims of the kind that have been customary over the past several years. After analyzing the Company's contingent liabilities on a gross basis and, based upon past experience with resolution of its product liability and employment practices claims and the limits of the primary, excess, and umbrella liability insurance coverages that are available with respect to pending claims, management believes that adequate provision has been made to cover any potential liability not covered by insurance, and that the ultimate liability, if any, arising from these actions should not have a material adverse effect on Roper's consolidated financial position, results of operations or cash flows.

Over recent years there has been an increase in certain U.S. states in asbestos-related litigation claims against numerous industrial companies. Roper or its subsidiaries have been named defendants in some such cases. No significant resources have been required by Roper to respond to these cases and the Company believes it has valid defenses to such claims and, if required, intends to defend them vigorously. Given the state of these claims it is not possible to determine the potential liability, if any.

Roper's financial statements include accruals for potential product liability and warranty claims based on its claims experience. Such costs are accrued at the time revenue is recognized.

A summary of the warranty accrual activity for the six months ended June 30, 2013 is presented below (in thousands):

Balance at December 31, 2012	$	9,755
Additions charged to costs and expenses*		14,935
Deductions		(5,900	)
Other		(243	)
Balance at June 30, 2013	$	18,547

* During the second quarter of 2013, the Company identified a vendor-supplied component within a refrigeration system valve that did not meet its quality standards, and $9.1 million was expensed to cover the estimated cost of replacing the faulty components for customers.

XML

Inventories

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Inventories

6. Inventories

	June 30,2013			December 31,2012
	(in thousands)
Raw materials and supplies	$	123,437		$	121,573
Work in process		33,648			29,725
Finished products		84,639			81,536
Inventory reserves		(44,266	)		(41,967	)
	$	197,458		$	190,867

XML

Basis of Presentation

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Basis of Presentation

1. Basis of Presentation

The accompanying condensed consolidated financial statements for the three and six month periods ended June 30, 2013 and 2012 are unaudited. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all adjustments, which include only normal recurring adjustments, necessary to state fairly the financial position, results of operations, comprehensive income and cash flows of Roper Industries, Inc. and its subsidiaries ("Roper" or the "Company") for all periods presented. The December 31, 2012 financial position data included herein was derived from the audited consolidated financial statements included in the 2012 Annual Report on Form 10-K ("Annual Report") filed on February 25, 2013 with the Securities and Exchange Commission ("SEC") but does not include all disclosures required by U.S. generally accepted accounting principles ("GAAP").

Roper's management has made a number of estimates and assumptions relating to the reporting of assets and liabilities and the disclosure of contingent assets and liabilities to prepare these condensed consolidated financial statements in conformity with GAAP. Actual results could differ from those estimates.

The results of operations for the three and six month periods ended June 30, 2013 are not necessarily indicative of the results to be expected for the full year. You should read these unaudited condensed consolidated financial statements in conjunction with Roper's consolidated financial statements and the notes thereto included in its Annual Report.

XML

Fair Value of Financial Instruments (Details) (USD $) In Millions, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Debt Instrument [Line Items]
Maturity Date	Jan. 15, 2034
Short-term Debt [Line Items]
Underlying risk	interest rate risk
Notional amount	$ 500
Type of instrument	interest rate swaps
Amount of hedged item	500
Description of hedged item	$500 million senior notes due 2013
Basis spread on Variable rate	4.377%
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Fair Value, Option, Reasons for Election	The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy. The Company has determined the swaps to be Level 2 in the FASB fair value hierarchy, and uses inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks in order to value the instruments.
Fair Value Inputs - Level 2
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Interest Rate Fair Value Hedge Asset	1.2
Senior Notes due 2013
Short-term Debt [Line Items]
ST Debt Instrument, Face Amount	500
ST Debt Instrument, Maturity Date	Aug. 15, 2013
Fair Value of Debt Instrument	503
Convertible Notes
Short-term Debt [Line Items]
ST Debt Instrument, Face Amount	10
Fair Value of Debt Instrument	10
Senior notes due 2017
Debt Instrument [Line Items]
Face Value of Debt Instrument	400
Maturity Date	Nov. 15, 2017
Long-term Debt, Fair Value	394
Senior Notes due 2018
Debt Instrument [Line Items]
Face Value of Debt Instrument	800
Maturity Date	Oct. 01, 2018
Long-term Debt, Fair Value	786
Senior Notes due 2019
Debt Instrument [Line Items]
Face Value of Debt Instrument	500
Maturity Date	Sep. 01, 2019
Long-term Debt, Fair Value	582
Senior notes due 2022
Debt Instrument [Line Items]
Face Value of Debt Instrument	500
Maturity Date	Nov. 15, 2022
Long-term Debt, Fair Value	$ 477

XML

Earnings Per Share (Tables)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Schedule Of Weighted Average Number Of Shares Outstanding Basic To Diluted

	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Basic shares outstanding		99,089		97,460		98,983		97,249
Effect of potential common stock:
Common stock awards		882		1,129		884		1,172
Senior subordinated convertible notes		191		1,030		204		1,079
Diluted shares outstanding		100,162		99,619		100,071		99,500

XML

Fair Value of Financial Instruments

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Fair Value of Financial Instruments

9. Fair Value of Financial Instruments

Roper's debt at June 30, 2013 included $2.7 billion of fixed-rate senior notes with the following fair values (in millions):

$500 million senior notes due 2013	$	503
$400 million senior notes due 2017		394
$800 million senior notes due 2018		786
$500 million senior notes due 2019		582
$500 million senior notes due 2022		477

The fair values of the senior notes are based on the trading prices of the notes, which the Company has determined to be Level 2 in the FASB fair value hierarchy.  Short-term debt included $10 million of fixed-rate convertible notes which were at fair value due to the ability of note holders to exercise the conversion option of the notes.

The Company manages interest rate risk by maintaining a combination of fixed- and variable-rate debt, which may include interest rate swaps to convert fixed-rate debt to variable-rate debt, or to convert variable-rate debt to fixed-rate debt.   At June 30, 2013, an aggregate notional amount of $500 million in interest rate swaps designated as fair value hedges effectively changed Roper's $500 million senior notes due 2013 with a fixed interest rate of 6.625% to a variable-rate obligation at a weighted average spread of 4.377% plus the 3 month London Interbank Offered Rate ("LIBOR").

The swaps are recorded at fair value in the balance sheet as assets or liabilities, and the changes in fair value of both the interest rate swap and the hedged senior notes due 2013 are recorded as interest expense. At June 30, 2013, the fair value of the swap was an asset balance of $1.2 million and was reported in other current assets. There was a corresponding increase of $0.2 million in the notes being hedged, which was reported as current portion of long-term debt.  The impact on earnings for the six months ended June 30, 2013 was immaterial. The Company has determined the swaps to be Level 2 in the FASB fair value hierarchy, and uses inputs other than quoted prices that are observable for the asset or liability, including interest rates, yield curves and credit risks in order to value the instruments.

XML

Inventories (Tables)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Inventories

	June 30,2013			December 31,2012
	(in thousands)
Raw materials and supplies	$	123,437		$	121,573
Work in process		33,648			29,725
Finished products		84,639			81,536
Inventory reserves		(44,266	)		(41,967	)
	$	197,458		$	190,867

XML

Business Acquisitions (Tables)

6 Months Ended

Jun. 30, 2013

Business Acquisitions [Abstract]

Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]

Current assets	$	59,813
Identifiable intangibles		465,500
Goodwill		679,999
Other assets		5,798
Total assets acquired		1,211,110
Current liabilities		(24,717	)
Long-term deferred tax liability		(164,319	)
Other liabilities		(6,524	)
Net assets acquired	$	1,015,550

XML

Document and Entity Information (USD $)	6 Months Ended
	Jun. 30, 2013	Dec. 31, 2012
Document and Entity Information [Abstract]
Entity Registrant Name	Roper Industries Inc
Entity Central Index Key	0000882835
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Public Float		$ 9,748,714,212
Entity Common Stock, Shares Outstanding	99,183,286
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013

XML

Stock Based Compensation (Tables)

6 Months Ended

Jun. 30, 2013

Notes to Financial Statements [Abstract]

Stock Based Compensation Expense

	Three months endedJune 30,				Six months endedJune 30,
	2013		2012		2013		2012
Stock based compensation	$	13,307	$	9,749	$	26,284	$	19,704
Tax effect recognized in net income		4,658		3,412		9,199		6,896
Windfall tax benefit/(shortfall), net		1,245		3,551		5,557		10,966

Weighted average assumptions used to value option grants

	Six months ended June 30,
	2013	2012
Fair value per share ($)	36.55	29.39
Risk-free interest rate (%)	0.78	0.82
Expected option life (years)	5.19	5.22
Expected volatility (%)	36.22	36.55
Expected dividend yield (%)	0.57	0.59